NeuroVigil Completes Second Financing Round

La Jolla, California-based neurotechnology company NeuroVigil completed a second financing round.

The round, of undisclosed amount, was led by Dr. Howard Morgan with participation from space entrepreneur Elon Musk, venture capitalist Tim Draper, and venture capital firms Draper Fisher Jurvetson (DFJ) and Zone Ventures.

Led by chairman and CEO, Dr. Philip Low, who owns about 89% of the company, NeuroVigil has developed proprietary technology which leverages the dynamic oscillations produced across the sleep/wake cycle in order to systematically scan the human brain for signs of pathologic activity, years in advance of cognitive or behavioral symptoms.
Launched in 2007, the company has an active program on assistive neurotechnologies based at the NASA Research Park, in Mountain View, California.

NeuroVigil is also responsible for the iBrain™ portable brain monitor that has been used since 2009 by companies like Roche and Novartis to gather data from the brain in clinical trials for research purposes, including from children with autism and outpatients. Typically the company owns all the intellectual property and biomarkers generated from such collaborations including any generated by its clients and has access to an international portfolio of pending and granted patents.

It has also launched in 2011, at the request of NeuroVigil advisor and theoretical physicist Stephen Hawking, a program to help individuals with ALS communicate by thought alone, and has developed substantial intellectual property on this topic.



Join the discussion